Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain

European Journal of Pharmacology

Volumn 313, Issue 3, 1996, Pages 181-186

  Karolewicz, Beata ^a   Antkiewicz Michaluk, Lucyna ^a   Michaluk, Jerzy ^a   Vetulani, Jerzy ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Adaptation; Catalepsy; Chronic treatment; Doipamine metabolism; Haloperidol; Pimozide

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HALOPERIDOL; HOMOVANILLIC ACID; NEUROLEPTIC AGENT; PIMOZIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DRUG WITHDRAWAL; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUPERSENSITIVITY;

EID: 0030591789     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00451-7     Document Type: Article

References (29)

1. Antkiewicz-Michaluk, L., J. Michaluk, I. Romañska and J. Vetulani, 1993, Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine. Psychopharmacology 111, 457.
2. 2+ channels, Eur. J. Pharmacol. 294, 459.
3. Burt D.R., I. Creese and S.H. Snyder, 1977, Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in the brain, Science 196, 326.
4. Cessalet, M.F., 1984, Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis, Neuroscience 12, 347.
5. Clow, A., A. Theodorou, P. Jenner, C.D. Marsden, 1980, Changes in rat striatal dopamine turnover and receptor activity during one year neuroleptic administration, Eur. J. Pharmacol. 63, 135.
6. Delini-Stula, A. and C. Morpurgo, 1968, Influence of amphetamine and scopolamine on the catalepsy induced by diencephalic lesions in rats, Int. J. Neuropharmacol. 7, 391.
7. 2+ channel blocker in heart, Mol. Pharmacol. 37, 752.
8. Feinberg, S.S., S.R. Kay, L.R. Elijovich, A. Fiszbein and L.A. Opler, 1988, Pimozide treatment of the negative schizophrenic syndrome: an open trial, J. Clin. Psychiatry 49, 235.
9. Fleminger, S., N.M.J. Rupniak, M.D. Hall, P. Jenner, C.D. Marsden, 1983, Changes in apomorphine-induced stereotypy, as a result of subacute neuroleptic treatment, correlates with increased D-2 receptor but not increases in D-1 receptors, Biochem. Pharmacol. 32, 2921.
10. 3 dopamine receptor, J. Pharmacol. Exp. Ther. 268, 417.
11. Gould, R.J., K.M.M. Murphy, I.J. Reynolds and S.H. Snyder, 1983, Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonist, Proc. Natl. Acad. Sci. USA, 80, 5122.
12. 2 dopamine receptors, J. Neurosci. 8, 2361.
13. Hyttel, J., J.J. Larsen, A.V. Christensen and J. Arnt, 1985, Receptor binding profiles of neuroleptics, in: Dyskinesia. Research and Treatment, Psychopharmacology, Suppl. 2, 9.
14. Izosaki, M., N. Minami and T. Nakashima, 1994, Pharmacological evidence for regulation of Na(+)-Ca(++ ) exchange by calcium/calmodulin-dependent protein kinase in isolated bovine adrenal medullary cells, J. Pharmacol. Exp. Ther. 270, 104.
15. Janssen, P.A.J., C.J.E. Niemegeers K.H.L. Schellenkens, A. Dresse, M.F. Leanerts, A. Pinchard, W.K.A. Schaper, J.M. Van Nueten and F.J. Verruggen, 1968, Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug, Arzneim.-Forsch. 18, 261.
16. MacKenzie, R.G., M.J. Zigmond, 1985, Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum, Eur. J. Pharmacol. 113, 159.
17. Mamczarz, J., B. Karolewicz, E. Antkiewicz-Michaluk and J. Vetulani, 1994, Co-administration of nifedipine with neuroleptics prevents development of activity changes during withdrawal, Pol. J. Pharmacol. 46, 75.
18. McGuire, B.E., E. Akuffo and G.E. Choon, 1994, Somatic sexual hallucinations and erotomanic delusions in a mentally handicapped woman, J. Intellect. Disabil. Res, 38, 79.
19. Miller, R., 1987, Multiple calcium channels and neuronal function, Science 235, 46.
20. Muller, P. and P. Seeman, 1978, Dopaminergic supersensitivity after neuroleptics: time course and specificity, Psychopharmacology 60, 1.
21. Nowak, J.Z., S. Arbilla, S.G. Dahl and S.Z. Langer, 1990, Antagonism of presynaptic dopamine receptors by phenothiazine drug metabolites, Life Sci. 46, 443.
22. Opler, L.A. and S.S. Feinberg, 1991, The role of pimozide in clinical psychiatry: a review, J. Clin. Psychiatry 52, 221.
23. Roth, B.L., S.C. Craigo, M.S. Choudhary, A. Uluer, F.J. Monsma, J.Y. Shen, H.Y. Meltzer and D.R. Sibley, 1994, Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors, J. Pharmacol. Exp. Ther. 268, 1403.
24. 4 receptors bind inactive (+)-aporphines, suggesting neuroleptic role. Sulpiride not stereoselective, Eur. J. Pharmacol. 233, 173.
25. Seeman, P., T. Lee, M. Chan-Wong and K. Wong, 1976, Antipsychotic drug doses and neuroleptic/dopamine receptors, Nature 261, 717.
26. Stafford, J.E., L.S. Jackson, T.J. Forrest, A. Barrow and R.F. Palmer, 1984, Haloperidol pharmacokinetics: a preliminary study in rhesus monkeys using a new radioimmunoassay procedure, J. Pharmacol. Methods 6, 261.
27. Van Rossum, J.M., 1967, The Significance of Dopamine Receptor Blockade for the Action of Neuroleptic Drugs, Neuro-Psycho-Pharmacology, ed. H. Brill (Excerpta Medica, Amsterdam) p. 321.
28. Vetulani, J, 1973, The action of neuroleptics in rats with altered catecholamine metabolism. Part I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol and thioridazine, Pol. J. Pharmacol. Pharm. 25, 41.
29. Weiss, B., W.C. Prozialeck and T.L. Wallace, 1982, Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications, Biochem. Pharmacol. 31, 2217.